Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pancreas Cancer: early-phase trial registry
30 of 55 indexed Pancreas Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #254 of 28,707 conditions by registered trial count.
55 US clinical trials · 30 currently recruiting · #254 of 28,707 conditions by registered trial count
Pancreas Cancer: 55 US clinical trials tracked, 30 recruiting.
Pancreas Cancer is the subject of 55 registered US clinical trials on ClinicalTrials.gov, 30 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most active sponsor is A2 Biotherapeutics, running 3 of these trials.
Enrollment posture brief
Registry condition pancreas-cancer
OPEN 30 | RECR 55% | LATE 2 | EARLY 29 | RANK #254 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)
Pancreas Cancer lists 30 open slots (55% of 55 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pancreas Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pancreas Cancer is recruiting above its size-band peers.
30 of 55 indexed trials (54.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Pancreas Cancer trials is spread across many organizations.
A2 Biotherapeutics accounts for 3 of 55 trials (5.5%). 41 distinct sponsors appear on at least one study for this condition label.
-
Typical Pancreas Cancer enrolment sits around 60 participants.
Median target enrolment is 60 among the 55 trials that report a genuine target (sentinel values excluded). 32 of those (58.2%) plan for fewer than 100 participants.
-
Pancreas Cancer research is mostly interventional.
42 interventional and 13 observational studies make up this index (76.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
55 total, page 2 of 2
Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer
GlobeImmune
NCT00300950
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
National Cancer Institute (NCI)
NCT02311361
Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX
Massachusetts General Hospital
NCT03798769
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery
Washington University School of Medicine
NCT05111353
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Novita Pharmaceuticals
NCT03199586
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 8 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Pancreas Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pancreas Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pancreas Cancer page
55 registered trials, 30 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 30 Pancreas Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- A2 Biotherapeutics sponsors the most Pancreas Cancer trials on record, review their full trial history before evaluating a specific study. See A2 Biotherapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pancreas Cancer condition card totals 55 registered trials; most-linked intervention Gemcitabine; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.